Department of Research and Innovation

A Phase 2, Double-blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Crohn’s DiseaseStatus: Recruiting nowClinicalTrial.gov Identifier: NCT02405442Aim: To evaluation the safety and efficacy of GS-5745 in adults with active Crohn’s disease.

Single centre, open label Phase 1/Phase 2 study to evaluate the safety and efficacy of Dietzia C79793-74 in moderate to severe Crohn’s diseaseStatus: Enrolling by invitation onlyANZCTR Trial ID: ACTRN12614000465651Aim: To see if treatment with Dietzia C79793-74 in patients with Crohn’s disease is safe and effective in reducing disease severity and improving quality-of-life.